Steven H. Holtzman, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 57,573 shares at $13.01 ($749K) on 2012-05-31, disclosed to the SEC on 2012-06-04.
Open-market sale of $749k INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BIIB | SELL | 2014-11-12 | $578K | — | Filing → |
| BIIB | SELL | 2014-10-02 | $579K | — | Filing → |
| BIIB | SELL | 2014-05-20 | $353K | — | Filing → |